Guided Therapeutics, Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price dropped 14.4% during trading on Tuesday . The stock traded as low as $0.10 and last traded at $0.10. Approximately 102 shares changed hands during trading, a decline of 100% from the average daily volume of 26,143 shares. The stock had previously closed at $0.12.
Guided Therapeutics Trading Down 14.4 %
The company has a fifty day moving average of $0.12 and a 200 day moving average of $0.12.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- What is the S&P 500 and How It is Distinct from Other Indexes
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- What Are Dividend Champions? How to Invest in the Champions
- Lowe’s Stock: Hold Now, Buy it When it Dips
- How to Invest in Insurance Companies: A Guide
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg&h=45&w=95&zc=2){kind=logo}
